8 studies were found.

1.		No longer recruiting	Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma Conditions: adult soft tissue sarcoma; gastrointestinal stromal tumor
2.		No longer recruiting	Chemotherapy in Treating Patients With Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor Condition: metastatic tumors of the Ewing's family
3.		No longer recruiting	Comparison of Two Different Doses of STI571 in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor Condition: gastrointestinal stromal tumor
4.		No longer recruiting	Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma Conditions: adult soft tissue sarcoma; ovarian sarcoma; Brain Tumor; uterine sarcoma
5.		No longer recruiting	Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma Conditions: Soft Tissue Sarcoma; Uterine Cancer
6.		No longer recruiting	STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma Conditions: stage/cell type, small intestine cancer; cellular diagnosis, adult soft tissue sarcoma; cellular diagnosis, uterine sarcoma; Cancer; ...
7.		No longer recruiting	Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma Conditions: adult soft tissue sarcoma; clear cell sarcoma of the kidney; ovarian sarcoma; Pheochromocytoma; uterine sarcoma
8.		No longer recruiting	Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma Conditions: adult soft tissue sarcoma; ovarian sarcoma; kidney tumor; uterine sarcoma